Add to ORKGEffect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind tria
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Therapy-induced mucositis and dysphagia puts head and neck (H&N) cancer patients at increased risk f...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Aim: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic properties. ...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Journal Article; Research Support, Non-U.S. Gov't; Review;Use of n-3 fatty acids (FA) has been repor...
In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsa...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
The project identified changes in molecular markers of antioxidant status and muscle atrophy during ...
We provide a systematic review to support the European Palliative Care Research Collaboration develo...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...
Abstract: Cancer cachexia is an involuntary weight loss of more than 10 % of premorbid weight, caus...
The acute-phase protein response is associated with accelerated weight loss and shortened survival i...
The management of cancer patients is frequently complicated by the occurrence of cachexia, a complex...
Background & Aims: There are few well-designed studies evaluating the effect of oral nutrition suppl...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Therapy-induced mucositis and dysphagia puts head and neck (H&N) cancer patients at increased risk f...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Aim: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic properties. ...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Journal Article; Research Support, Non-U.S. Gov't; Review;Use of n-3 fatty acids (FA) has been repor...
In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsa...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
The project identified changes in molecular markers of antioxidant status and muscle atrophy during ...
We provide a systematic review to support the European Palliative Care Research Collaboration develo...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...
Abstract: Cancer cachexia is an involuntary weight loss of more than 10 % of premorbid weight, caus...
The acute-phase protein response is associated with accelerated weight loss and shortened survival i...
The management of cancer patients is frequently complicated by the occurrence of cachexia, a complex...
Background & Aims: There are few well-designed studies evaluating the effect of oral nutrition suppl...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...
Therapy-induced mucositis and dysphagia puts head and neck (H&N) cancer patients at increased risk f...
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss an...